Trial intelligence / Profile preview

Efficacy of local anesthetic infiltration for pudendal neuralgia

2021-001494-23Phase 3Active

Sponsor
Groupe Hospitalier Diaconesses Croix Saint-Simon
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of lidocaine in pudendal neuralgia (PN) (2 arms), sponsored by Groupe Hospitalier Diaconesses Croix Saint-Simon. Primary endpoint: Primary pain response at 1 month. Started Apr 2021; status: active.

02

Drugs

lidocaine
03

Conditions

pudendal neuralgia (PN)

Beyond the preview

Go deeper on 2021-001494-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-001494-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call